Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3636)
All Articles published online
|
Jan 21, 2011 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Klaus J, Reinshagen M, Herdt K, Schröter C, Adler G, Boyen GBV, Tirpitz CV. Bones and Crohn’s: No benefit of adding sodium fluoride or ibandronate to calcium and vitamin D. World J Gastroenterol 2011; 17(3): 334-342 [PMID: 21253392 DOI: 10.3748/wjg.v17.i3.334] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i3/334.htm |
| Number | Citing Articles |
| 1 |
John Melek, Atsushi Sakuraba. Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review. Clinical Gastroenterology and Hepatology 2014; 12(1): 32 doi: 10.1016/j.cgh.2013.08.024
|
| 2 |
Jinming Wang, Jiarong Yang, Xiaofang Cheng, Rui Xiao, Yangfei Zhao, Huimiao Xu, Yaya Zhu, Zipeng Yan, Mohammad Mehdi Ommati, Ram Kumar Manthari, Jundong Wang. Calcium Alleviates Fluoride-Induced Bone Damage by Inhibiting Endoplasmic Reticulum Stress and Mitochondrial Dysfunction. Journal of Agricultural and Food Chemistry 2019; 67(39): 10832 doi: 10.1021/acs.jafc.9b04295
|
| 3 |
Xiaojing Zhao, Changcheng Zhou, Han Chen, Jingjing Ma, Yunjuan Zhu, Peixue Wang, Yi Zhang, Haiqin Ma, Hongjie Zhang. Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease. Medicine 2017; 96(11): e6378 doi: 10.1097/MD.0000000000006378
|
| 4 |
Jens Walldorf, Annette Krummenerl, Kristin Engler, Juliane Busch, Matthias M. Dollinger, Thomas Seufferlein, Jörg G. Albert. Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?. Journal of Crohn's and Colitis 2013; 7(11): 901 doi: 10.1016/j.crohns.2012.12.008
|
| 5 |
Liwei Yao, Haiqing Wang, Wenwei Dong, Zhenxin Liu, Haijiao Mao. Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease. Medicine 2017; 96(3): e5861 doi: 10.1097/MD.0000000000005861
|
| 6 |
Yan Hu, Xiaoting Chen, Xiaojing Chen, Shuang Zhang, Tianyan Jiang, Jing Chang, Yanhong Gao. Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/2736547
|
| 7 |
Sjoerd F. Bakker, Vincent K. Dik, Birgit I. Witte, Paul Lips, Jan C. Roos, Adriaan A. Van Bodegraven. Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation. Journal of Crohn's and Colitis 2013; 7(5): 377 doi: 10.1016/j.crohns.2012.06.003
|
| 8 |
Zhen Guo, Rong Wu, Jianfeng Gong, Weiming Zhu, Yi Li, Ning Li, Jieshou Li. The Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Crohn’s Disease: A Meta-Analysis. Digestive Diseases and Sciences 2013; 58(4): 915 doi: 10.1007/s10620-012-2465-0
|
| 9 |
Adriaan A. van Bodegraven, Chris J.J. Mulder, Nathalie Bravenboer. Marcus and Feldman's Osteoporosis. 2021; : 1069 doi: 10.1016/B978-0-12-813073-5.00043-5
|